Pharmaceutical impurities workshop
Dec 11, 2018 - Dec 11, 2018

Watch pharmaceutical impurities webinars on-demand

Hear how you can optimize your impurity analysis workflows to obtain greater productivity, sensitivity, accuracy and reproducibility to meet increasing regulatory requirements and lower limits of detection. Learn how to achieve all of this, whilst also increasing laboratory efficiency and reducing the cost per sample.

Dr. Christian Zeine presents an overview of the topic of pharmaceutical impurities including what constitutes an impurity, the various types of impurities, the regulatory guidelines and detection limits and the important points to consider during impurity testing. In addition, briefly introducing why to use reference standards and the main points to consider during their use.

Speaker: Dr. Christian Zeine, LGC Standards


Sign-up below to get access to the webinar recordings.

For questions about these webinars, please contact us at

In this webinar, Broughton Laboratories presents their work in the area of pharmaceutical impurities focusing on method development and validation of related substances, stability studies and impurity profiling and the investigation of unknown impurities.

Speaker: Elaine Corcoran, Broughton Laboratories

We discuss novel and existing inorganic impurities and how ICP-MS can being utilized and optimized to obtain ultimate sensitivity and rapid detection and quantitiation of such impurities. Also how automatic method development can improve productivity.

Speakers: Kirsty Mcintyre, LGC Standards

Strategies are shown to improve productivity, reduce cost per sample and gain deeper insights for organic impurity analysis using novel UHPLC and detector technology. How to achieve confirmation, identification and quantification simultaneously with a multi-detector approach. 

Speaker: Dr. Heiko Herrmann, Thermo Fisher Scientific

Additional Resources

Prior to the workshop, why not take a look at these articles related to pharmaceutical impurities:

  • Introduction to pharmaceutical impurities: An Interview with Dr. Christian Zeine  - Read more
  • Monitoring pharmaceutical impurities - Read more